Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

242 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Bacteriophage Therapy for Difficult-to-Treat Infections: The Implementation of a Multidisciplinary Phage Task Force (The PHAGEFORCE Study Protocol).
Onsea J, Uyttebroek S, Chen B, Wagemans J, Lood C, Van Gerven L, Spriet I, Devolder D, Debaveye Y, Depypere M, Dupont L, De Munter P, Peetermans WE, van Noort V, Merabishvili M, Pirnay JP, Lavigne R, Metsemakers WJ. Onsea J, et al. Among authors: peetermans we. Viruses. 2021 Aug 5;13(8):1543. doi: 10.3390/v13081543. Viruses. 2021. PMID: 34452408 Free PMC article.
Safety and efficacy of phage therapy in difficult-to-treat infections: a systematic review.
Uyttebroek S, Chen B, Onsea J, Ruythooren F, Debaveye Y, Devolder D, Spriet I, Depypere M, Wagemans J, Lavigne R, Pirnay JP, Merabishvili M, De Munter P, Peetermans WE, Dupont L, Van Gerven L, Metsemakers WJ. Uyttebroek S, et al. Among authors: peetermans we. Lancet Infect Dis. 2022 Aug;22(8):e208-e220. doi: 10.1016/S1473-3099(21)00612-5. Epub 2022 Mar 3. Lancet Infect Dis. 2022. PMID: 35248167 Review.
Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program.
Thijs L, Quintens C, Vander Elst L, De Munter P, Depypere M, Metsemakers WJ, Vles G, Liesenborghs A, Neefs J, Peetermans WE, Spriet I. Thijs L, et al. Among authors: peetermans we. Antibiotics (Basel). 2022 May 23;11(5):702. doi: 10.3390/antibiotics11050702. Antibiotics (Basel). 2022. PMID: 35625346 Free PMC article.
Emerging and re-emerging infectious diseases.
Peetermans WE, De Munter P. Peetermans WE, et al. Acta Clin Belg. 2007 Sep-Oct;62(5):337-41. doi: 10.1179/acb.2007.051. Acta Clin Belg. 2007. PMID: 18229468 Review. No abstract available.
Prospective assessment of breakthrough infections and neurotoxicity and their association with cefepime trough concentrations in patients with febrile neutropenia.
Gijsen M, Bekkers B, Maertens J, Lagrou K, Desmet S, Dreesen E, Peetermans WE, Debaveye Y, Spriet I. Gijsen M, et al. Among authors: peetermans we. Int J Antimicrob Agents. 2022 Jan;59(1):106472. doi: 10.1016/j.ijantimicag.2021.106472. Epub 2021 Oct 30. Int J Antimicrob Agents. 2022. PMID: 34757136
Q fever: a contemporary case series from a Belgian hospital.
Vanderbeke L, Peetermans WE, Saegeman V, De Munter P. Vanderbeke L, et al. Among authors: peetermans we. Acta Clin Belg. 2016 Oct;71(5):290-296. doi: 10.1080/17843286.2016.1165397. Epub 2016 Apr 27. Acta Clin Belg. 2016. PMID: 27118360
242 results